Hematology Archives

In a survey on end-of-life (EOL) discussions, hematologic oncologists reported that these discussions with patients who have blood cancers occur too late, according to a recent report.

Web Exclusives

High-Dose Chemo and Stem Cell Transplantation Results in Long-Term Survival for Patients With Amyloidosis

By

Kathy Boltz, PhD

October 27, 2015

Patients with light-chain amyloidosis who are treated with high-dose chemotherapy and autologous stem cell transplantation have the greatest success for long-term survival.

Providing telephone support to patients.

ONS Annual Congress 2015

Proactive telephone support reduces unplanned hospitalizations in blood cancers

By

Joyce Pagan

April 25, 2015

Implementing proactive telephone support reduced unplanned hospitalizations among patients with blood cancers by 70%.

Web Exclusives

Genetically engineered immunotoxin shows early promise for B-cell malignancies

By

Kathy Boltz, PhD

April 1, 2015

DT2219, a new bispecific ligand-directed diphtheria toxin, was found to be effective in a small group of patients with relapsed/refractory B-cell malignancies, according to clinical trial results.

Web Exclusives

Epigenetic therapy clinically active against several blood cancers

By

Kathy Boltz, PhD

April 22, 2014

Patients with a variety of hematologic cancers benefited from treatment with OTX015, a member of a new class of investigational epigenetic therapies that block the activity of bromodomain and extraterminal (BET)-bromodomain proteins.

Web Exclusives